Patients with premature coronary artery disease (CAD) have high rates of recurrent events and death. Information on long-term adherence to lipid-lowering therapy (LLT) and trends in medication-taking behavior in premature CAD is limited. We assessed temporal trends in LLT, factors associated with adherence to LLT, and the consequences of low adherence in a longitudinal cohort of patients with premature CAD.